- Continue Shopping
- Your Cart is Empty
Medtech Veteran and Serial Entrepreneur Jean-Pierre Desmarais joins Hexoskin's Board of Directors
Hexoskin announces today the nomination of Jean-Pierre Desmarais as an independent director on Hexoskin's Board of Directors.
Jean-Pierre Desmarais brings more than four decades in the medical device industry, spanning R&D, clinical research, regulatory affairs, and global commercialization. His background includes serving as Chief Scientific Officer at CryoCath Technologies (acquired by Medtronic) in the field of cardiac electrophysiology, President of Piramal Healthcare Bio-Orthopedics (acquired by Smith+Nephew), and CEO of Innovitech, an innovation advisory firm working across medical technology and aerospace. He currently serves as CEO of Leaflet solution who develops devices that facilitate transcatheter cardiac valve implantation.
Across his career, Jean-Pierre has guided medical technologies from early-stage development through regulatory approval, including FDA, EU CE, and other international pathways, and into global commercial and reimbursement markets. That perspective brings real value to the Hexoskin team as it accomplishes its mission: delivering medical wearables as a trusted source of digital biomarkers in cardiology, respiratory, neurology, and rare disease clinical trials.
About Hexoskin
Hexoskin is a Montreal-based medtech company that develops the Hexoskin Medical Shirt, a unique FDA-cleared wearable that continuously captures 3-lead ECG, dual-channel respiratory inductance plethysmography, and 3-axis accelerometry. Hexoskin's data is used as digital biomarkers and clinical endpoints in pharmaceutical trials spanning cardiology, respiratory, neurology, and rare disease programs, giving research teams continuous, clinical-grade physiological data outside traditional clinical settings. Behind this work sits a large proprietary cardiorespiratory database spanning over 300 studies — a unique foundation that Hexoskin is building on through AI research focused on respiratory and neurological diseases.
Hexoskin in Basel for the Digital Biomarkers in Clinical Trials & Clinical Trial Innovation Summits June 23-24
Hexoskin is proud to sponsor this week the 9th Digital Biomarkers in Clinical Trials Summit and the 6th Clinical Trial Innovation Summit, hosted in partnership with Roche in Basel, Switzerland.
View full article →Hexoskin in San Diego for BIO 2026
Hexoskin will be in San Diego this June 22-24 for the BIO 2026 International Convention, the world's largest and most comprehensive event for the global biotechnology and life sciences industry. Hosted by the Biotechnology Innovation Organization, the gathering brings together over 20,000 leaders from startups, Pharma companies, academia, and government agencies
View full article →Hexoskin at the Phoenix Global Forum 2026
Hexoskin's CEO Pierre-Alexandre Fournier will speak at the Phoenix Global Forum 2026 this May 13th at the Phoenix Convention Center.
He will be joined on stage by Jay Maningo-Salinas, Vice Chair, Research Administration at Mayo Clinic, and Brad Sorenson, founder and CEO at Providence Therapeutics to talk about healthcare innovation in biotech, medtech, and AI, and how the latest breakthrough offers an opportunity to fill health equity gaps in historically underrepresented populations.
The panel will be moderated by Jessica Boehm, reporter at Axios.
View full article →Hexoskin @ LSI USA 2026
Fresh off FDA clearance, Hexoskin will be in Dana Point this March at the annual LSI USA conference where we’ll be discussing our expansion plans with partners and investors.
We'll also present new developments about our AI models for clinical trials and remote diagnostics, and our digital biomarker pipeline in cardiology, respiratory diseases, nervous system disorders, and rare diseases.
Contact us if you're attending: contact@hexoskin.com
Hexoskin @ 2026 JP Morgan Conference
Hexoskin will be in San Francisco again this year during the 44th Annual J.P. Morgan Healthcare Conference, the largest life sciences investment event in the world.
We'll take the opportunity to meet with our clients and partners who use the Hexoskin software platform and wearables for clinical research, digital biomarker discovery, and medical AI development.
We'll also present new insights about the Hexoskin OneView platform for clinical research and our digital biomarker pipeline in cardiology, respiratory diseases, nervous system disorders, and rare diseases.
Contact us to book a meeting: contact@hexoskin.com
Hexoskin to Present at the HITLAB Innovation Summit 2025
Hexoskin's CEO Pierre-Alexandre Fournier is going to present our latest work in AI and digital biomarker development for clinical trials at the HITLAB Innovators Summit 2025 this December 2-4 in New York City.
Hexoskin Medical System Receives FDA 510(k) Clearance for Long-Term ECG and Respiratory Monitoring
The Hexoskin Medical System (HMS) is now an FDA-cleared, medical-grade smart shirt for continuous, long-term ECG, respiratory, and activity monitoring. It’s a premier remote monitoring solution for cardiopulmonary chronic conditions (COPD, Afib) and complements the validated AI-based digital biomarker platform for clinical trials in cardiovascular, respiratory, and rare diseases.
View full article →Hexoskin @ HLTH 2025
Hexoskin will be presenting its latest products and clinical advancements at HLTH USA 2025 next week in Las Vegas.
We'll take the opportunity to meet with our clients and partners who use the Hexoskin software platform and wearables to advance our knowledge of human physiology.
We'll also present our new Hexoskin OneView platform for research and our digital biomarker pipeline in cardiology, respiratory diseases, nervous system disorders, and rare diseases.
Contact us to book a meeting: contact@hexoskin.com
From Data Collection to Reporting: See How Hexoskin Streamlines Your Entire Physiological Monitoring Workflow
Join Our Free Technical Deep Dive on September 17, 2025
Effective physiological monitoring goes far beyond simple data collection. The real challenge for researchers, data scientists, and R&D professionals is managing the entire workflow, from organizing participant data to reporting meaningful insights. Juggling disparate tools for each step is inefficient and can compromise your project's integrity.
The Hexoskin platform is designed to solve this challenge by providing a single, seamless solution for your entire process. Join our exclusive webinar on September 17, 2025, at 11:00 am EDT to see how you can streamline every stage of your work.
What You Will Learn in This Deep Dive Session:
This 60-minute session will provide a live demonstration of the comprehensive tools built into the Hexoskin platform. We will cover:
- Data Collection: How to capture continuous, high-resolution physiological data with our smart clothing, designed for minimal participant burden.
- Data Organization: Best practices for using our integrated cohort management and data synchronization tools to keep your projects organized and secure.
- Data Analysis: A look at the platform’s built-in visualization and analysis features that help you get to insights faster.
- Data Reporting: How to use streamlined export options and reporting tools to prepare your findings for publication or presentation.
- Expert Guidance: You'll have the chance to ask our technical team your specific questions during a live Q&A session.
Who Should Attend?
This event is perfect for researchers, developers, AI teams, data scientists, and R&D professionals. It is also ideal for any organization currently implementing or considering physiological or remote monitoring solutions.
Don't miss this opportunity to master your workflow. Register today for our free technical deep dive!
